A new multi-test approach may spot hidden blood vessel damage before symptoms appear

NCT ID NCT06325800

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This observational study is testing whether a combination of non-invasive measurements—including blood pressure monitoring, ultrasound, blood and urine tests, and a light-based technique called photoplethysmography—can detect early damage to blood vessels and organs in adults at increased cardiovascular risk. The study will enroll about 1,000 participants and will not assign any treatments. The goal is to see which markers and devices are reliable and whether they can improve early risk assessment and prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multimodal cardiovascular phenotyping (non-invasive imaging, blood/urine biomarkers, photoplethysmography)
What this could lead to
If successful, this could lead to better tools for early detection of vascular damage, improving cardiovascular risk assessment and prevention.
What could go wrong
This is an observational study, so it won't test treatments. The measurements may not prove reliable or improve prediction beyond existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Complejo Hospitalario Universitario de Santiago de Compostela

    RECRUITING

    Santiago de Compostela, A Coruña, 15706, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.